Prognostic factors in diffuse large B-cell lymphoma

Internal Medicine

Volumn 45, Issue 5, 2006, Pages 227-228

  Niitsu, Nozomi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

B CELL LYMPHOMA; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CELL DIFFERENTIATION; DISEASE MARKER; EDITORIAL; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GERMINAL CENTER; HUMAN; LARGE CELL LYMPHOMA; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 33645670391     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.0142     Document Type: Editorial

References (4)

1. Shipp MA. A predictive model for aggressive non-Hodgkin's lymphomas. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329: 987-994, 1993.
2. Tomita N, et al. Prognostic factors in diffuse large B-cell lymphoma treated by rest-adopted therapy. Intern Med 45: 247-252, 2006
3. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct type of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000.
4. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350: 1828-1837, 2004.